Immunologie

Inefficacy of infliximab in primary Sjögren’s syndrome: results of the randomized, controlled trial of Remicade in Primary Sjögren’s syndrome (TRIPSS)

Arthritis Rheum. 2004 Apr ; 50(4): 1270-6 Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puechal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Transition of care adulthood in severe asthmatic
Success stories - Immunologie - Facultatif

Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real-life

Real-Life Omalizumab Exposure and Discontinuation
Success stories - Immunologie - Facultatif

Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)

Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study)
Immunologie

Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study)